← Back to Patent Explorer
US4381292A Expired / Lapsed US ⏱️ 0.0 years remaining

Anti-human T-lymphocyte monoclonal antibody

Assignee: Leland Stanford Junior University
•
Filing: 1980-11-14
•
Granted: 1983-04-26
•
Expires: 2000-11-14
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Mammalian monoclonal antibodies specific for an antigen diagnostic for thymocytes, normal peripheral T cells and some null cells. The antibodies which distinguish among subpopulations of T cells, find use in assays, cell sorting, and immunosupression.

Inventors

  • 👤 Charles P. Bieber
  • 👤 Frank D. Howard

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 02:15
CPC Classifications
C; C07; C07K; C07K16/00; C07K16/18; C07K16/28; G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/53; G01N33/569; G01N33/56966; G01N33/56972; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/808

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 25 words
Mammalian monoclonal antibodies specific for the lymphocyte antigen Leu-5, specifically binding to thymocytes and E-rosette forming peripheral blood lymphocytes and inhibiting human thymocyte rosette formation.
Claim 2
Dependent Claim 25 words
Mammalian monoclonal antibodies specific for the lymphocyte antigen Leu-5, specifically binding to thymocytes and E-rosette forming peripheral blood lymphocytes and inhibiting human thymocyte rosette formation.
Claim 3
Dependent Claim 11 words
Antibodies according to claim 1, wherein said mammal is a mouse.
Claim 4
Dependent Claim 37 words
Mammalian monoclonal antibodies specific for the lymphocyte surface antigen Leu-5 having a label providing a detectible signal, specifically binding to human thymocytes and human peripheral blood lymphocytes which form E-rosettes and inhibiting E-rosette formation of human thymocytes.
Claim 5
Dependent Claim 37 words
Mammalian monoclonal antibodies specific for the lymphocyte surface antigen Leu-5 having a label providing a detectible signal, specifically binding to human thymocytes and human peripheral blood lymphocytes which form E-rosettes and inhibiting E-rosette formation of human thymocytes.
Claim 6
Dependent Claim 30 words
Mammalian monoclonal antibodies according to claim 3, wherein said label is a member of the group consisting of a radioactive isotope, enzyme, fluorescent compound, chemiluminescent compound, ferromagnetic atom, or particle.
Claim 7
Dependent Claim 15 words
The mammalian monoclonal antibody according to claim 4, wherein said label is a radioactive isotope.
Claim 8
Dependent Claim 15 words
A mammalian monoclonal antibody according to claim 4, wherein said label is a fluorescent molecule.
Claim 9
Dependent Claim 56 words
A method for determining the presence of a cell suspected of containing a Leu-5 surface antigen, said method comprises combining a sample suspected of containing said cell having said Leu-5 surface antigen with mammalian monoclonal antibody according to claim 3; and detecting the presence of said Leu-5 by means of said signal provided by said label.
Claim 10
Dependent Claim 13 words
A method according to claim 7, wherein said label is a radioactive isotope.
Claim 11
Dependent Claim 36 words
A method for supressing the immunological response by a mammalian host to an immunogen which comprises introducing into said host a sufficient amount of mammalian monoclonal antibody according to claim 1 to suppress said immunological response.

References Cited (Backward Citations)

US4196265A Cited
EP0018794A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-04-25 1986-10-25 1987-04-26 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-04-25 1990-10-25 1991-04-26 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-04-25 1994-10-25 1995-04-26 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag